HNF4A and metabolic dysfunction-associated steatotic liver disease: However, neither downstream targets Shp (Nr0b2) nor Hnf4a differed between the groups (Fig. 3c), consistent with an altered FXR-SHP signaling axis, as reported in NAFLD and NASH38.